Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Vertical Research Downgrades Huntsman to Hold

Vertical Research Downgrades Huntsman to Hold

Vertical Research analyst Kevin McCarthy downgrades Huntsman (NYSE:HUN) from Buy to Hold.

byBenzinga Newsdesk

February 22, 2023

1 minute read

Vertical Research analyst Kevin McCarthy downgrades Huntsman (NYSE:HUN) from Buy to Hold.

What’s Driving Tesla Stock Higher Premarket?

By Shanthi Rexaline

June 21, 6:00 AM

Shares of Tesla, Inc. (NASDAQ:TSLA) continued their upward climb in premarket trading on Wednesday, demonstrating relentless momentum. During premarket…

TSLA

Huntington Ingalls Beats On Q1, Reaffirms FY23 Expectations

By Akanksha Bakshi

May 4, 1:44 PM

Huntington Ingalls Industries Inc (NYSE:HII) reported a first-quarter FY23 sales and service revenue increase of 3.8% year-over-year to $2.672 billion, beating…

HII

Analyst Ratings

What 5 Analyst Ratings Have To Say About Fifth Third Bancorp

By Benzinga Insights

September 12, 10:21 AM

Within the last quarter, Fifth Third Bancorp (NASDAQ:FITB) has observed the following analyst ratings:

FITB

Wellstar Health Partners With Axon To Enhance Hospital Security And De-Escalation; Terms Not Disclosed

By Benzinga Newsdesk

September 7, 8:07 AM

One of the largest health systems in Georgia to equip security officers with TASER 7 devices, as well as provide de-escalation tools and training, to promote a safer hospital environment

AXON

Vertical Research Downgrades Huntsman to Hold

Related Posts

What’s Driving Tesla Stock Higher Premarket?

Huntington Ingalls Beats On Q1, Reaffirms FY23 Expectations

What 5 Analyst Ratings Have To Say About Fifth Third Bancorp

Wellstar Health Partners With Axon To Enhance Hospital Security And De-Escalation; Terms Not Disclosed